{
    "root": "416cdb61-31fb-4554-835f-a7744aa33b61",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "TRANEXAMIC ACID",
    "value": "20250301",
    "ingredients": [
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "ETHYLCELLULOSE, UNSPECIFIED",
            "code": "7Z8S9VYZ4B"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "CROSCARMELLOSE SODIUM",
            "code": "M28OL1HH48"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "TRANEXAMIC ACID",
            "code": "6T84R30KC1"
        }
    ],
    "indications": "tranexamic acid tablets indicated treatment cyclic heavy menstrual bleeding females reproductive potential [ ( 14 ) ] .",
    "contraindications": "• 1,300 mg three times day ( 3,900 mg/day ) maximum 5 days monthly menstruation ( 2.1 ) • renal impairment : lower needed ( maximum 5 days menstruation ) serum creatinine concentration ( cr ) higher 1.4 mg/dl ( 2.2 ) cr 1.4 mg/dl ≤ 2.8 mg/dl : 1,300 mg two times day ( 2,600 mg/day ) cr 2.8 mg/dl ≤ 5.7 mg/dl : 1,300 mg day ( 1,300 mg/day ) cr 5.7 mg/dl : 650 mg day ( 650 mg/day )",
    "warningsAndPrecautions": "tranexamic acid tablets , usp provided white white oval-shaped tablets debossed a64 one side “ ˄ ” side supplied : quantity package type ndc number 15 tablets bottle 82804-208-15 storage store room temperature 25° c ( 77° f ) ; excursions permitted 15-30° c ( 59-86° f ) . [ usp controlled room temperature ] .",
    "adverseReactions": "• concomitant combined hormonal contraceptives ( 4.1 ) • active thromboembolic disease history intrinsic risk thrombosis thromboembolism , including retinal vein artery occlusion ( 4.1 ) • hypersensitivity tranexamic acid ( 4.2 )",
    "indications_original": "Tranexamic acid tablets are indicated for the treatment of cyclic heavy menstrual bleeding in females of reproductive potential     [see Clinical Studies (       14)].",
    "contraindications_original": "• 1,300 mg three times a day (3,900 mg/day) for a maximum of 5 days during monthly menstruation ( 2.1 ) • Renal impairment : Lower dosage is needed (for a maximum of 5 days during menstruation) if serum creatinine concentration (Cr) is higher than 1.4 mg/dL ( 2.2 ) o Cr above 1.4 mg/dL and ≤ 2.8 mg/dL: 1,300 mg two times a day (2,600 mg/day) o Cr above 2.8 mg/dL and ≤ 5.7 mg/dL: 1,300 mg once a day (1,300 mg/day) o Cr above 5.7 mg/dL: 650 mg once a day (650 mg/day)",
    "warningsAndPrecautions_original": "Tranexamic acid tablets, USP are provided as white to off white oval-shaped tablets debossed with A64 on one side and “˄” on the other side and are supplied as:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Quantity\n                              \n                           \n                           \n                              \n                                 Package Type\n                              \n                           \n                           \n                              \n                                 NDC Number\n                              \n                           \n                        \n                        \n                           \n                              15 tablets\n                           \n                           \n                              Bottle\n                           \n                           \n                              82804-208-15\n                           \n                        \n                     \n                  \n                  \n                     Storage\n                  \n                  Store at room temperature 25° C (77° F); excursions permitted to 15-30° C (59-86° F). [See USP Controlled Room Temperature].",
    "adverseReactions_original": "• Concomitant use of combined hormonal contraceptives ( 4.1 ) • Active thromboembolic disease or a history or intrinsic risk of thrombosis or thromboembolism, including retinal vein or artery occlusion ( 4.1 ) • Hypersensitivity to tranexamic acid ( 4.2 )"
}